NCT06054321View on ClinicalTrials.gov

Psychopharmacotherapy for Depressive Patients

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

August 3, 2022

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2030

Conditions
Major Depressive Disorder
Interventions
DRUG

stepwise pharmacotherapy

In the stepwise pharmacotherapy group, treatment strategies (augmentation with antipsychotics (aripiprazole), augmentation with mood stabilizer (lithium),combination (mirtazapine)) will be determined every 3 weeks.

DRUG

antidepressant monotherapy group

In the antidepressant monotherapy group, dosage escalation will be determined every 3 weeks.

Trial Locations (1)

61469

RECRUITING

Chonnam National University Hospital, Gwangju

All Listed Sponsors
lead

Chonnam National University Hospital

OTHER